Cover Story
By Matthew Bin Han Ong
Directors of NCI-designated cancer centers are facing a new set of challenges in a polarizing, high-stakes election year.Â
In Brief
Clinical Roundup
Drugs & Targets
NCI Trials
NCI Trials for June 2024
The National Cancer Institute approved the following clinical research studies last month. Â
Trending Stories
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Karen Knudsen to leave ACS
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation - Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72